Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 53.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $52.031 million which missed the analyst consensus estimate of $54.263 million by 4.11 percent. This is a 22.41 percent decrease over sales of $67.057 million the same period last year.